API SUPPLIERS

API Suppliers

0

US DMFs Filed

0

CEP/COS Certifications

0

JDMFs Filed

0

Other Certificates

0

Other Suppliers

0

API REF. PRICE (USD / KG)

64

API Market Place

0

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

0

Europe

0

Canada

0

Australia

0

South Africa

0

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

FDF Market Place

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Also known as: E-7090, Tasurgratinib, E7090, 1622204-21-0, Tn7cud1nga, 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamido)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-n-methyl-1h-indole-1-carboxamide

Molecular Formula

C₃₂H₃₇N₅O₆

Molecular Weight

587.7 g/mol

InChI Key

IBHOLSBDZMIPPT-UHFFFAOYSA-N

FDA UNII

TN7CUD1NGA

Tasurgratinib is an inhibitor of the fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) pathway, with potential antineoplastic activity. Upon administration, tasurgratinib selectively interferes with the binding of FGF to FGFR through an as of yet not fully elucidated mechanism. This inhibits FGFR-mediated signaling and leads to both cell proliferation inhibition and cell death in FGFR-overexpressing tumor cells. FGFR is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation, and survival; its expression is upregulated in many tumor cell types.

1 2D Structure

E7090

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]pyridin-4-yl]oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamide

2.1.2 InChI

InChI=1S/C32H37N5O6/c1-33-32(40)37-14-10-25-19-29(28(21-27(25)37)42-18-17-41-2)43-26-7-11-34-30(20-26)35-31(39)24-5-3-22(4-6-24)23-8-12-36(13-9-23)15-16-38/h3-7,10-11,14,19-21,23,38H,8-9,12-13,15-18H2,1-2H3,(H,33,40)(H,34,35,39)

2.1.3 InChI Key

IBHOLSBDZMIPPT-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CNC(=O)N1C=CC2=CC(=C(C=C21)OCCOC)OC3=CC(=NC=C3)NC(=O)C4=CC=C(C=C4)C5CCN(CC5)CCO

2.2 Other Identifiers

2.2.1 UNII

TN7CUD1NGA

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. E-7090

2. Tasurgratinib

3. E7090

4. 1622204-21-0

5. Tn7cud1nga

6. 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamido)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-n-methyl-1h-indole-1-carboxamide

7. 1h-indole-1-carboxamide, 5-((2-((4-(1-(2-hydroxyethyl)-4-piperidinyl)benzoyl)amino)-4-pyridinyl)oxy)-6-(2-methoxyethoxy)-n-methyl-

8. 5-((2-(((4-(1-(2-hydroxyethyl)piperidin-4-yl)phenyl)carbonyl)amino)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-n-methyl-1h-indole-1-carboxamide

9. 5-[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]pyridin-4-yl]oxy-6-(2-methoxyethoxy)-n-methylindole-1-carboxamide

10. Unii-tn7cud1nga

11. Tasurgratinib [inn]

12. Chembl3686884

13. Schembl15955142

14. Gtpl11414

15. Bdbm142256

16. E-7090 [who-dd]

17. Bcp29727

18. Ex-a2908

19. Nsc806388

20. Nsc-806388

21. Sb18854

22. Example 22 [wo2014129477a1]

23. Hy-101466

24. Cs-0021430

25. E 7090; E7090

26. Us8933099, 22

27. Q27896113

28. 1-(2-hydroxyethyl)-7-(2-methoxyethoxy)-n-methyl-3- Oxo-7h-6-oxa-4-aza-7(5)-indola-5(2,4)-pyridina-1(4)-piperidina-2(1,4)-benzenaheptaphane-7-carboxamide

2.4 Create Date

2014-10-06

3 Chemical and Physical Properties

Molecular Formula	C₃₂H₃₇N₅O₆
Molecular Weight	587.7 g/mol
XLogP3	3.1
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	11
Exact Mass	587.27438392 g/mol
Monoisotopic Mass	587.27438392 g/mol
Topological Polar Surface Area	127 Å²
Heavy Atom Count	43
Formal Charge	0
Complexity	880
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1